Brief: Viva Biotech Sees Revenue To Increase By Over 13% For Year

VIVA Biotech Holdings

16/03/2023 10:26

March 16 (Reuters) - VIVA Biotech Holdings  1873.HK :
    * SEES REVENUE TO INCREASE BY OVER 13% FOR YEAR
    * SEES NET LOSS OF NOT MORE THAN RMB510 MILLION FOR YEAR
    * SEES ADJUSTED NET LOSS OF GROUP FOR YEAR ON IFRS WILL BE
NOT
MORE THAN RMB140 MILLION
    * EXPECTED NET LOSS DUE TO MARKET FLUCTUATION RESULTING IN
NEGATIVE FAIR VALUE CHANGES, AMONG OTHERS

Source text for Eikon:  ID: 
Further company coverage:  1873.HK 

 ((Reuters.Briefs@thomsonreuters.com;))